Loading…

Divergent Gemycircularvirus in HIV-Positive Blood, France

We retrospectively analyzed the impact of HLA-DPB1 mismatches in a large cohort of 1342 French patients who underwent 10/10 HLA-matched unrelated HSCT. A significant impact of HLA-DPB1 allelic mismatches (2 vs 0) was observed in severe acute GVHD (aGVHDIII-IV) (risk ratio (RR)=1.73, confidence inter...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2015-11, Vol.21 (11), p.2096-2098
Main Authors: Uch, Rathviro, Fournier, Pierre-Edouard, Robert, Catherine, Blanc-Tailleur, Caroline, Galicher, Vital, Barre, Romain, Jordier, François, de Micco, Philippe, Raoult, Didier, Biagini, Philippe
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c694t-fe8f0672378643a2d3f4e9f853e8f9045c62eb3da0420e426cc8b1a5a839100f3
cites cdi_FETCH-LOGICAL-c694t-fe8f0672378643a2d3f4e9f853e8f9045c62eb3da0420e426cc8b1a5a839100f3
container_end_page 2098
container_issue 11
container_start_page 2096
container_title Emerging infectious diseases
container_volume 21
creator Uch, Rathviro
Fournier, Pierre-Edouard
Robert, Catherine
Blanc-Tailleur, Caroline
Galicher, Vital
Barre, Romain
Jordier, François
de Micco, Philippe
Raoult, Didier
Biagini, Philippe
description We retrospectively analyzed the impact of HLA-DPB1 mismatches in a large cohort of 1342 French patients who underwent 10/10 HLA-matched unrelated HSCT. A significant impact of HLA-DPB1 allelic mismatches (2 vs 0) was observed in severe acute GVHD (aGVHDIII-IV) (risk ratio (RR)=1.73, confidence interval (CI) 95% 1.09-2.73, P=0.019) without impact on OS, TRM, relapse and chronic GVHD (cGVHD). According to the T-cell epitope 3 (TCE3)/TCE4 HLA-DPB1 disparity algorithm, 37.6% and 58.4% pairs had nonpermissive HLA-DPB1, respectively. TCE3 and TCE4 disparities had no statistical impact on OS, TRM, relapse, aGVHD and cGVHD. When TCE3/TCE4 disparities were analyzed in the graft-vs-host or host-vs-graft (HVG) direction, only a significant impact of TCE4 nonpermissive disparities in the HVG direction was observed on relapse (RR=1.34, CI 95% 1.00-1.80, P=0.048). In conclusion, this French retrospective study shows an adverse prognosis of HLA-DPB1 mismatches (2 vs 0) on severe aGVHD and of nonpermissive TCE4 HVG disparities on relapse after HLA-matched 10/10 unrelated HSCT.
doi_str_mv 10.3201/eid2111.150486
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_281464e526e54b3586f6d5b98c2447d4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A435452892</galeid><doaj_id>oai_doaj_org_article_281464e526e54b3586f6d5b98c2447d4</doaj_id><sourcerecordid>A435452892</sourcerecordid><originalsourceid>FETCH-LOGICAL-c694t-fe8f0672378643a2d3f4e9f853e8f9045c62eb3da0420e426cc8b1a5a839100f3</originalsourceid><addsrcrecordid>eNqNkk1vEzEQhlcIREvhyhFFQkJUYoO_Y1-QQqFNpEhFfPRqeb2zG1ebdbF3I_rvcdgQdVEOyAdbM8_7jj2eLHuJ0ZQShN-DKwnGeIo5YlI8yk4xkigXiKvHhzNDJ9mzGG8RwkminmYnRDApscSnmfrkthBqaLvJFWzurQu2b0zYutDHiWsni-VN_sVH1yVs8rHxvnw3uQymtfA8e1KZJsKL_X6W_bj8_P1ika-ur5YX81VuhWJdXoGskJgROpOCUUNKWjFQleQ0JRRi3AoCBS0NYgQBI8JaWWDDjaQKI1TRs2w5-Jbe3Oq74DYm3GtvnP4T8KHWJnTONqCJxEww4EQAZwXlUlSi5IWSljA2K1ny-jB43fXFBkqbnh1MMzIdZ1q31rXfaiYIIYwng_PBYP2PbDFf6V0stZhypdgWJ_btvljwP3uInd64aKFpTAu-jxrPiEScCoQS-npAa5Oe4drKp-p2h-s5o5xxIhVJVH6ESn8H6aq-hcql8IifHuHTKmHj7FHB-UiQmA5-dbXpY9TLb1__n72-GbNvHrBrME23jr7pO-fbePTGNvgYA1SHHmOkd_Ou9_Ouh3lPglcPP_SA_x1w-hu5DPPy</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1728053600</pqid></control><display><type>article</type><title>Divergent Gemycircularvirus in HIV-Positive Blood, France</title><source>PubMed Central</source><creator>Uch, Rathviro ; Fournier, Pierre-Edouard ; Robert, Catherine ; Blanc-Tailleur, Caroline ; Galicher, Vital ; Barre, Romain ; Jordier, François ; de Micco, Philippe ; Raoult, Didier ; Biagini, Philippe</creator><creatorcontrib>Uch, Rathviro ; Fournier, Pierre-Edouard ; Robert, Catherine ; Blanc-Tailleur, Caroline ; Galicher, Vital ; Barre, Romain ; Jordier, François ; de Micco, Philippe ; Raoult, Didier ; Biagini, Philippe</creatorcontrib><description>We retrospectively analyzed the impact of HLA-DPB1 mismatches in a large cohort of 1342 French patients who underwent 10/10 HLA-matched unrelated HSCT. A significant impact of HLA-DPB1 allelic mismatches (2 vs 0) was observed in severe acute GVHD (aGVHDIII-IV) (risk ratio (RR)=1.73, confidence interval (CI) 95% 1.09-2.73, P=0.019) without impact on OS, TRM, relapse and chronic GVHD (cGVHD). According to the T-cell epitope 3 (TCE3)/TCE4 HLA-DPB1 disparity algorithm, 37.6% and 58.4% pairs had nonpermissive HLA-DPB1, respectively. TCE3 and TCE4 disparities had no statistical impact on OS, TRM, relapse, aGVHD and cGVHD. When TCE3/TCE4 disparities were analyzed in the graft-vs-host or host-vs-graft (HVG) direction, only a significant impact of TCE4 nonpermissive disparities in the HVG direction was observed on relapse (RR=1.34, CI 95% 1.00-1.80, P=0.048). In conclusion, this French retrospective study shows an adverse prognosis of HLA-DPB1 mismatches (2 vs 0) on severe aGVHD and of nonpermissive TCE4 HVG disparities on relapse after HLA-matched 10/10 unrelated HSCT.</description><identifier>ISSN: 1080-6040</identifier><identifier>EISSN: 1080-6059</identifier><identifier>DOI: 10.3201/eid2111.150486</identifier><identifier>PMID: 26488181</identifier><language>eng</language><publisher>United States: U.S. National Center for Infectious Diseases</publisher><subject>Adolescent ; Adult ; Aged ; Algorithms ; Allografts ; blood ; Child ; Child, Preschool ; Divergent Gemycircularvirus in HIV-Positive Blood, France ; DNA, Single-Stranded ; Female ; France ; gemycircularvirus ; Graft vs Host Disease ; Hematologic Neoplasms ; Hematology ; Hematopoietic Stem Cell Transplantation ; HIV ; HIV Infections - epidemiology ; HIV Infections - virology ; HIV Seropositivity - blood ; HIV Seropositivity - virology ; HIV-1 - pathogenicity ; HLA-DP beta-Chains ; Host vs Graft Reaction ; Human health and pathology ; Humans ; Letter ; Letters to the Editor ; Life Sciences ; Male ; Microbiology and Parasitology ; Middle Aged ; Molecular Sequence Data ; Unrelated Donors ; Virology ; viruses</subject><ispartof>Emerging infectious diseases, 2015-11, Vol.21 (11), p.2096-2098</ispartof><rights>COPYRIGHT 2015 U.S. National Center for Infectious Diseases</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c694t-fe8f0672378643a2d3f4e9f853e8f9045c62eb3da0420e426cc8b1a5a839100f3</citedby><cites>FETCH-LOGICAL-c694t-fe8f0672378643a2d3f4e9f853e8f9045c62eb3da0420e426cc8b1a5a839100f3</cites><orcidid>0000-0002-2895-5824 ; 0000-0002-0633-5974</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622245/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622245/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26488181$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01235994$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Uch, Rathviro</creatorcontrib><creatorcontrib>Fournier, Pierre-Edouard</creatorcontrib><creatorcontrib>Robert, Catherine</creatorcontrib><creatorcontrib>Blanc-Tailleur, Caroline</creatorcontrib><creatorcontrib>Galicher, Vital</creatorcontrib><creatorcontrib>Barre, Romain</creatorcontrib><creatorcontrib>Jordier, François</creatorcontrib><creatorcontrib>de Micco, Philippe</creatorcontrib><creatorcontrib>Raoult, Didier</creatorcontrib><creatorcontrib>Biagini, Philippe</creatorcontrib><title>Divergent Gemycircularvirus in HIV-Positive Blood, France</title><title>Emerging infectious diseases</title><addtitle>Emerg Infect Dis</addtitle><description>We retrospectively analyzed the impact of HLA-DPB1 mismatches in a large cohort of 1342 French patients who underwent 10/10 HLA-matched unrelated HSCT. A significant impact of HLA-DPB1 allelic mismatches (2 vs 0) was observed in severe acute GVHD (aGVHDIII-IV) (risk ratio (RR)=1.73, confidence interval (CI) 95% 1.09-2.73, P=0.019) without impact on OS, TRM, relapse and chronic GVHD (cGVHD). According to the T-cell epitope 3 (TCE3)/TCE4 HLA-DPB1 disparity algorithm, 37.6% and 58.4% pairs had nonpermissive HLA-DPB1, respectively. TCE3 and TCE4 disparities had no statistical impact on OS, TRM, relapse, aGVHD and cGVHD. When TCE3/TCE4 disparities were analyzed in the graft-vs-host or host-vs-graft (HVG) direction, only a significant impact of TCE4 nonpermissive disparities in the HVG direction was observed on relapse (RR=1.34, CI 95% 1.00-1.80, P=0.048). In conclusion, this French retrospective study shows an adverse prognosis of HLA-DPB1 mismatches (2 vs 0) on severe aGVHD and of nonpermissive TCE4 HVG disparities on relapse after HLA-matched 10/10 unrelated HSCT.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Algorithms</subject><subject>Allografts</subject><subject>blood</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Divergent Gemycircularvirus in HIV-Positive Blood, France</subject><subject>DNA, Single-Stranded</subject><subject>Female</subject><subject>France</subject><subject>gemycircularvirus</subject><subject>Graft vs Host Disease</subject><subject>Hematologic Neoplasms</subject><subject>Hematology</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>HIV</subject><subject>HIV Infections - epidemiology</subject><subject>HIV Infections - virology</subject><subject>HIV Seropositivity - blood</subject><subject>HIV Seropositivity - virology</subject><subject>HIV-1 - pathogenicity</subject><subject>HLA-DP beta-Chains</subject><subject>Host vs Graft Reaction</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Letter</subject><subject>Letters to the Editor</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Microbiology and Parasitology</subject><subject>Middle Aged</subject><subject>Molecular Sequence Data</subject><subject>Unrelated Donors</subject><subject>Virology</subject><subject>viruses</subject><issn>1080-6040</issn><issn>1080-6059</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqNkk1vEzEQhlcIREvhyhFFQkJUYoO_Y1-QQqFNpEhFfPRqeb2zG1ebdbF3I_rvcdgQdVEOyAdbM8_7jj2eLHuJ0ZQShN-DKwnGeIo5YlI8yk4xkigXiKvHhzNDJ9mzGG8RwkminmYnRDApscSnmfrkthBqaLvJFWzurQu2b0zYutDHiWsni-VN_sVH1yVs8rHxvnw3uQymtfA8e1KZJsKL_X6W_bj8_P1ika-ur5YX81VuhWJdXoGskJgROpOCUUNKWjFQleQ0JRRi3AoCBS0NYgQBI8JaWWDDjaQKI1TRs2w5-Jbe3Oq74DYm3GtvnP4T8KHWJnTONqCJxEww4EQAZwXlUlSi5IWSljA2K1ny-jB43fXFBkqbnh1MMzIdZ1q31rXfaiYIIYwng_PBYP2PbDFf6V0stZhypdgWJ_btvljwP3uInd64aKFpTAu-jxrPiEScCoQS-npAa5Oe4drKp-p2h-s5o5xxIhVJVH6ESn8H6aq-hcql8IifHuHTKmHj7FHB-UiQmA5-dbXpY9TLb1__n72-GbNvHrBrME23jr7pO-fbePTGNvgYA1SHHmOkd_Ou9_Ouh3lPglcPP_SA_x1w-hu5DPPy</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Uch, Rathviro</creator><creator>Fournier, Pierre-Edouard</creator><creator>Robert, Catherine</creator><creator>Blanc-Tailleur, Caroline</creator><creator>Galicher, Vital</creator><creator>Barre, Romain</creator><creator>Jordier, François</creator><creator>de Micco, Philippe</creator><creator>Raoult, Didier</creator><creator>Biagini, Philippe</creator><general>U.S. National Center for Infectious Diseases</general><general>Centers for Disease Control and Prevention</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2895-5824</orcidid><orcidid>https://orcid.org/0000-0002-0633-5974</orcidid></search><sort><creationdate>20151101</creationdate><title>Divergent Gemycircularvirus in HIV-Positive Blood, France</title><author>Uch, Rathviro ; Fournier, Pierre-Edouard ; Robert, Catherine ; Blanc-Tailleur, Caroline ; Galicher, Vital ; Barre, Romain ; Jordier, François ; de Micco, Philippe ; Raoult, Didier ; Biagini, Philippe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c694t-fe8f0672378643a2d3f4e9f853e8f9045c62eb3da0420e426cc8b1a5a839100f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Algorithms</topic><topic>Allografts</topic><topic>blood</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Divergent Gemycircularvirus in HIV-Positive Blood, France</topic><topic>DNA, Single-Stranded</topic><topic>Female</topic><topic>France</topic><topic>gemycircularvirus</topic><topic>Graft vs Host Disease</topic><topic>Hematologic Neoplasms</topic><topic>Hematology</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>HIV</topic><topic>HIV Infections - epidemiology</topic><topic>HIV Infections - virology</topic><topic>HIV Seropositivity - blood</topic><topic>HIV Seropositivity - virology</topic><topic>HIV-1 - pathogenicity</topic><topic>HLA-DP beta-Chains</topic><topic>Host vs Graft Reaction</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Letter</topic><topic>Letters to the Editor</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Microbiology and Parasitology</topic><topic>Middle Aged</topic><topic>Molecular Sequence Data</topic><topic>Unrelated Donors</topic><topic>Virology</topic><topic>viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uch, Rathviro</creatorcontrib><creatorcontrib>Fournier, Pierre-Edouard</creatorcontrib><creatorcontrib>Robert, Catherine</creatorcontrib><creatorcontrib>Blanc-Tailleur, Caroline</creatorcontrib><creatorcontrib>Galicher, Vital</creatorcontrib><creatorcontrib>Barre, Romain</creatorcontrib><creatorcontrib>Jordier, François</creatorcontrib><creatorcontrib>de Micco, Philippe</creatorcontrib><creatorcontrib>Raoult, Didier</creatorcontrib><creatorcontrib>Biagini, Philippe</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints In Context</collection><collection>Gale In Context: Science</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Emerging infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uch, Rathviro</au><au>Fournier, Pierre-Edouard</au><au>Robert, Catherine</au><au>Blanc-Tailleur, Caroline</au><au>Galicher, Vital</au><au>Barre, Romain</au><au>Jordier, François</au><au>de Micco, Philippe</au><au>Raoult, Didier</au><au>Biagini, Philippe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Divergent Gemycircularvirus in HIV-Positive Blood, France</atitle><jtitle>Emerging infectious diseases</jtitle><addtitle>Emerg Infect Dis</addtitle><date>2015-11-01</date><risdate>2015</risdate><volume>21</volume><issue>11</issue><spage>2096</spage><epage>2098</epage><pages>2096-2098</pages><issn>1080-6040</issn><eissn>1080-6059</eissn><abstract>We retrospectively analyzed the impact of HLA-DPB1 mismatches in a large cohort of 1342 French patients who underwent 10/10 HLA-matched unrelated HSCT. A significant impact of HLA-DPB1 allelic mismatches (2 vs 0) was observed in severe acute GVHD (aGVHDIII-IV) (risk ratio (RR)=1.73, confidence interval (CI) 95% 1.09-2.73, P=0.019) without impact on OS, TRM, relapse and chronic GVHD (cGVHD). According to the T-cell epitope 3 (TCE3)/TCE4 HLA-DPB1 disparity algorithm, 37.6% and 58.4% pairs had nonpermissive HLA-DPB1, respectively. TCE3 and TCE4 disparities had no statistical impact on OS, TRM, relapse, aGVHD and cGVHD. When TCE3/TCE4 disparities were analyzed in the graft-vs-host or host-vs-graft (HVG) direction, only a significant impact of TCE4 nonpermissive disparities in the HVG direction was observed on relapse (RR=1.34, CI 95% 1.00-1.80, P=0.048). In conclusion, this French retrospective study shows an adverse prognosis of HLA-DPB1 mismatches (2 vs 0) on severe aGVHD and of nonpermissive TCE4 HVG disparities on relapse after HLA-matched 10/10 unrelated HSCT.</abstract><cop>United States</cop><pub>U.S. National Center for Infectious Diseases</pub><pmid>26488181</pmid><doi>10.3201/eid2111.150486</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-2895-5824</orcidid><orcidid>https://orcid.org/0000-0002-0633-5974</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1080-6040
ispartof Emerging infectious diseases, 2015-11, Vol.21 (11), p.2096-2098
issn 1080-6040
1080-6059
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_281464e526e54b3586f6d5b98c2447d4
source PubMed Central
subjects Adolescent
Adult
Aged
Algorithms
Allografts
blood
Child
Child, Preschool
Divergent Gemycircularvirus in HIV-Positive Blood, France
DNA, Single-Stranded
Female
France
gemycircularvirus
Graft vs Host Disease
Hematologic Neoplasms
Hematology
Hematopoietic Stem Cell Transplantation
HIV
HIV Infections - epidemiology
HIV Infections - virology
HIV Seropositivity - blood
HIV Seropositivity - virology
HIV-1 - pathogenicity
HLA-DP beta-Chains
Host vs Graft Reaction
Human health and pathology
Humans
Letter
Letters to the Editor
Life Sciences
Male
Microbiology and Parasitology
Middle Aged
Molecular Sequence Data
Unrelated Donors
Virology
viruses
title Divergent Gemycircularvirus in HIV-Positive Blood, France
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T01%3A01%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Divergent%20Gemycircularvirus%20in%20HIV-Positive%20Blood,%20France&rft.jtitle=Emerging%20infectious%20diseases&rft.au=Uch,%20Rathviro&rft.date=2015-11-01&rft.volume=21&rft.issue=11&rft.spage=2096&rft.epage=2098&rft.pages=2096-2098&rft.issn=1080-6040&rft.eissn=1080-6059&rft_id=info:doi/10.3201/eid2111.150486&rft_dat=%3Cgale_doaj_%3EA435452892%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c694t-fe8f0672378643a2d3f4e9f853e8f9045c62eb3da0420e426cc8b1a5a839100f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1728053600&rft_id=info:pmid/26488181&rft_galeid=A435452892&rfr_iscdi=true